Tadalafil PAH OrPha 20 mg, Filmtabletten - 56 Swissmedic Key 67968001 Registration Holder OrPha Swiss GmbH Name Tadalafil PAH OrPha 20 mg, Filmtabletten Date of registration 23.07.2020 Original/Generic Generic Introduction of Sequence 23.07.2020 ATC-Classification Tadalafil (G04BE08) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.10. Show package size 56 Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 455.04 Limitation Yes Limitation text
Deductible 10 % Consumer price 511.30 Feedback FB Daily cost GTIN 7680679680012 Medication Code Synthetika Pharmacode Disponibility
Composition tadalafilum 20 mg, lactosum 312.5 mg, carmellosum natricum conexum, natrii laurilsulfas, hydroxypropylcellulosum, polysorbatum 80, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 2.8 mg, E 171, triacetinum, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 1.91 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Tadalafilum 20 mg
BAG: Active Agent Dose Tadalafilum 20 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum E 171 color. E 172 color. Hydroxypropylcellulosum Hypromellosum Überzug Lactosum 312.5 mg Lactose Monohydrate 2.8 mg Magnesii Stearas Natrii Laurilsulfas Polysorbatum 80 Pro Compresso Obducto Talcum Triacetinum
Source Data was imported : 04.12.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
